The government has released a draft Gazette Notification suggesting changes to prevent duplicate viral testing of blood products, seeking public feedback. The proposed amendments aim to align testing requirements with global standards and eliminate unnecessary testing procedures. These changes are part of an effort to streamline regulations, enhance testing efficiency, and ensure patient safety.
The draft specifies that the initial pool of human plasma for fractionation must undergo specific tests before manufacturing plasma-derived medicinal products. This includes screening for Hepatitis B, Hepatitis C, and HIV markers to ensure safety. The new regulations aim to avoid redundant testing by eliminating the need to retest final products made from previously qualified plasma pools.
Stakeholders are urged to review the draft notification and provide feedback within the stipulated timeframe. In a related development, the government has initiated discussions on training 1.5 lakh multiskilled caregivers to address domestic needs and global opportunities in the care sector. The Union Budget 2026–27 also emphasizes strengthening the care ecosystem through training programs that encompass caregiving skills, wellness support, and medical device operation.
